Wealth Management Nebraska’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Hold
328
0.04% 76
2026
Q1
$302K Sell
328
-9
-3% -$9.12K 0.03% 80
2025
Q4
$362K Sell
337
-24
-7% -$22.9K 0.04% 73
2025
Q3
$275K Buy
361
+2
+0.6% +$1.49K 0.03% 77
2025
Q2
$278K Hold
359
0.04% 66
2025
Q1
$297K Buy
359
+96
+37% +$79.9K 0.05% 56
2024
Q4
$203K Buy
+263
New +$218K 0.03% 69

Other funds holding LLY

Wealth Management Nebraska's LLY Position: Q2 2026 in Review

Wealth Management Nebraska held its Eli Lilly (LLY) position steady in Q2 2026 at 328 shares worth $393K. The position accounts for 0.04% of the portfolio, ranked #76.

Wealth Management Nebraska first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Management Nebraska held 328 shares of Eli Lilly worth $393K as of Q2 2026.
  • Wealth Management Nebraska left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.04% of Wealth Management Nebraska's portfolio in Q2 2026, its #76 holding.
  • Wealth Management Nebraska first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Management Nebraska's 13F filing for Q2 2026, filed 27 Jul 2026.